Schedule 13D ownership disclosure

Bausch Health Cos., Inc.

Common Stock, no par value · CUSIP: 071734107

Event date: 2025-05-20

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Icahn Partners Master Fund LPReported CIK 0001322827

    Shares: 14,423,595.00 · Class: 3.9%

  • Icahn Offshore LPReported CIK 0001322825

    Shares: 14,423,595.00 · Class: 3.9%

  • Icahn Partners LPReported CIK 0001313666

    Shares: 20,297,523.00 · Class: 5.5%

  • Icahn Onshore LPReported CIK 0001322826

    Shares: 20,297,523.00 · Class: 5.5%

  • Icahn Capital LPReported CIK 0001412093

    Shares: 34,721,118.00 · Class: 9.4%

  • IPH GP LLCReported CIK 0001412091

    Shares: 34,721,118.00 · Class: 9.4%

  • Icahn Enterprises Holdings L.P.Reported CIK 0001034563

    Shares: 34,721,118.00 · Class: 9.4%

  • Icahn Enterprises G.P. Inc.Reported CIK 0001257324

    Shares: 34,721,118.00 · Class: 9.4%

  • Beckton Corp.Reported CIK 0001080113

    Shares: 34,721,118.00 · Class: 9.4%

  • Carl C. IcahnReported CIK 0000921669

    Shares: 34,721,118.00 · Class: 9.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001539497-25-001480
Form type
SCHEDULE 13D/A
Filer
Bausch Health Companies Inc.
CIK
CIK 885590
Filed
May 21, 2025
Reporting period
May 20, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub